The promise of PET/MRI is clear, but challenges remain when it comes to implementing, reading and billing the new technology. This is the second in a two-part series.
The institutions that adopted PET/MRI after its 2011 approval reflect on the changes in workflow and protocol, and the utility and future of the new technology. This is the first in a two-part series.
Washington University’s Mallinckrodt Institute of Radiology is imaging cervical cancer patients with hybrid PET/MR. Here’s what they’ve learned about this new modality.
Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.
Pamela Woodard, MD, of the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, discusses the challenges and benefits of being an early adopter of this technology.
Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.
Pamela Woodard, MD, of the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, discusses the challenges and benefits of being an early adopter of this technology.
